Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: A preliminary investigation

Biological Psychiatry

Volumn 76, Issue 9, 2014, Pages 734-741

  Leggio, Lorenzo ^a,b   Zywiak, William H ^c   Fricchione, Samuel R ^b   Edwards, Steven M ^f   De La Monte, Suzanne M ^e   Swift, Robert M ^d   Kenna, George A ^c  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e BROWN UNIVERSITY   (United States)

^f PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Craving; Cue reactivity; Feeding peptides; Ghrelin; Neuroendocrinology

Indexed keywords

GHRELIN; PLACEBO;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG TARGETING; FEMALE; FRUIT JUICE; HUMAN; MALE; NEUROENDOCRINOLOGY; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; ASSOCIATION; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PSYCHOLOGY; SALIVA; STATISTICS; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CRAVING; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GHRELIN; HEART RATE; HUMANS; MALE; MIDDLE AGED; SALIVA; STATISTICS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922661146     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.03.019     Document Type: Article

References (54)

1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. (2013): Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 382:1575-1586.
2. Edwards S, Kenna GA, Swift RM, Leggio L (2011): Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: A review. Curr Pharm Des 17: 1323-1332.
3. Leggio L (2009): Understanding and treating alcohol craving and dependence: Recent pharmacological and neuroendocrinological findings. Alcohol Alcohol 44:341-352.
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999): Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
5. Tschop M, Smiley DL, Heiman ML (2000): Ghrelin induces adiposity in rodents. Nature 407:908-913.
6. Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, et al. (2005): Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 29:1130-1136.
7. Katayama M, Nogami H, Nishiyama J, Kawase T, Kawamura K (2000): Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology 72:333-340.
8. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006): Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494:528-548.
9. Jiang H, Betancourt L, Smith RG (2006): Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 20:1772-1785.
10. Jerlhag E (2008): Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol 13:358-363.
11. Jerlhag E, Egecioglu E, Landgren S, Salome N, Heilig M, Moechars D, et al. (2009): Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 106:11318-11323.
12. Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA (2007): Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12:6-16.
13. Addolorato G, Capristo E, Leggio L, Ferrulli A, Abenavoli L, Malandrino N, et al. (2006): Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol Clin Exp Res 30:1933-1937.
14. Badaoui A, De Saeger C, Duchemin J, Gihousse D, de Timary P, Starkel P (2008): Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. Eur J Clin Invest 38:397-403.
15. de Timary P, Cani PD, Duchemin J, Neyrinck AM, Gihousse D, Laterre PF, et al. (2012): The loss of metabolic control on alcohol drinking in heavy drinking alcohol-dependent subjects. PloS One 7:e38682.
16. Kim DJ, Yoon SJ, Choi B, Kim TS, Woo YS, Kim W, et al. (2005): Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol 40:76-79.
17. Kraus T, Schanze A, Groschl M, Bayerlein K, Hillemacher T, Reulbach U, et al. (2005): Ghrelin levels are increased in alcoholism. Alcohol Clin Exp Res 29:2154-2157.
18. Leggio L, Ferrulli A, Cardone S, Nesci A, Miceli A, Malandrino N, et al. (2012): Ghrelin system in alcohol-dependent subjects: Role of plasma ghrelin levels in alcohol drinking and craving. Addict Biol 17: 452-464.
19. Koopmann A, von der Goltz C, Grosshans M, Dinter C, Vitale M, Wiedemann K, Kiefer F (2012): The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology 37:980-986.
20. Leggio L (2010): Role of the ghrelin system in alcoholism: Acting on the growth hormone secretagogue receptor to treat alcohol-related diseases. Drug News Perspect 23:157-166.
21. Vestergaard ET, Hansen TK, Gormsen LC, Jakobsen P, Moller N, Christiansen JS, Jorgensen JO (2007): Constant intravenous ghrelin infusion in healthy young men: Clinical pharmacokinetics and metabolic effects. Am J Physiol Endocrinol Metab 292:E1829-E1836.
22. Paulo RC, Brundage R, Cosma M, Mielke KL, Bowers CY, Veldhuis JD (2008): Estrogen elevates the peak overnight production rate of acylated ghrelin. J Clin Endocrinol Metab 93:4440-4447.
23. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS (2001): A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719.
24. Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, et al. (1999): Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386-1394.
25. Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987): Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122-126.
26. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB (2000): Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109:738-742.
27. Nijs IM, Franken IH, Muris P (2007): The modified Trait and State Food- Cravings Questionnaires: Development and validation of a general index of food craving. Appetite 49:38-46.
28. Monti PM, Rohsenow DJ, Hutchison KE (2000): Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving. Addiction 95(suppl 2):S229-S236.
29. White KD (1977): Salivation: A review and experimental investigation of major techniques. Psychophysiology 14:203-212.
30. Johnson BA, Ait-Daoud N, Roache JD (2005): The COMBINE SAFTEE: A structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. J Stud Alcohol Suppl 15: 157-167; discussion 140.
31. Levine J, Schooler NR (1986): SAFTEE: A technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22: 343-381.
32. Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ, Zweben A (2000): Alcoholism treatment and medical care costs from Project MATCH. Addiction 95:999-1013.
33. Drummond DC (2000): What does cue-reactivity have to offer clinical research? Addiction 95(suppl 2):S129-S144.
34. Zywiak WH, Westerberg VS, Connors GJ, Maisto SA (2003): Exploratory findings from the Reasons for Drinking Questionnaire. J Subst Abuse Treat 25:287-292.
35. Costantini VJ, Vicentini E, Sabbatini FM, Valerio E, Lepore S, Tessari M, et al. (2011): GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinology 94:158-168.
36. Cremonini F, Camilleri M, Vazquez Roque M, McKinzie S, Burton D, Baxter K, Zinsmeister AR (2006): Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology 131:1431-1439.
37. Ray LA, Hutchison KE, Tartter M (2010): Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des 16:2149-2158.
38. Kaur S, Ryabinin AE (2010): Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortincontaining neurons. Alcohol Clin Exp Res 34:1525-1534.
39. Bahi A, Tolle V, Fehrentz JA, Brunel L, Martinez J, Tomasetto CL, Karam SM (2013): Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides 43:48-55.
40. Cruz MT, Herman MA, Cote DM, Ryabinin AE, Roberto M (2013): Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. Neuropsychopharmacology 38:364-375.
41. Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M (2011): Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36:1178-1186.
42. Tong J, Dave N, Mugundu GM, Davis HW, Gaylinn BD, Thorner MO, et al. (2013): The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects. Eur J Endocrinol 168:821-828.
43. Heinz A, Beck A, Grusser SM, Grace AA, Wrase J (2009): Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14:108-118.
44. Lu S, Guan JL, Wang QP, Uehara K, Yamada S, Goto N, et al. (2002): Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 321:157-160.
45. Mondal MS, Date Y, Yamaguchi H, Toshinai K, Tsuruta T, Kangawa K, Nakazato M (2005): Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept 126:55-59.
46. Banks WA, Tschop M, Robinson SM, Heiman ML (2002): Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302: 822-827.
47. Freeman JN, do Carmo JM, Adi AH, da Silva AA (2013): Chronic central ghrelin infusion reduces blood pressure and heart rate despite increasing appetite and promoting weight gain in normotensive and hypertensive rats. Peptides 42:35-42.
48. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, et al. (2001): Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430-1435.
49. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C, Quon MJ (2007): Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab 292: E756-E764.
50. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, et al. (2001): Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280: R1483-R1487.
51. Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, Tschop M, et al. (2008): Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: A randomised, placebocontrolled, double-blind, double-crossover study. Br J Cancer 98: 300-308.
52. Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M (2004): Ghrelin, appetite, and gastric motility: The emerging role of the stomach as an endocrine organ. FASEB J 18:439-456.
53. Garin MC, Burns CM, Kaul S, Cappola AR (2013): Clinical review: The human experience with ghrelin administration. J Clin Endocrinol Metab 98:1826-1837.
54. Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E (2011): The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol 340:80-87.